George Vasmatzis

Computers and high-throughput sequencing technologies enabled an emerging field called genomics that will revolutionize the way we understand cancer and treat patients. Via comprehensive interrogation of the molecular and informational content of cells, genomics is adding immensely to the biological knowledge of cell normality and dysregulation that leads to cancer. In this talk, George Vasmatzis explains the Human Genome and how it’s read and interpreted, as well as how genomics can be used for cancer biomarker discovery and patient treatment.

George Vasmatzis, Ph.D., is the co-director of the Biomarker Discovery Program within the Center for Individualized Medicine. In addition to earning a doctorate in biomedical engineering, Dr. Vasmatzis has acquired experience in diverse disciplines, including bioinformatics, molecular biology and computational biology. His research team consists of bioinformatics specialists, molecular biologists, epidemiologists and pathologists. Dr. Vasmatzis’ laboratory has demonstrated success in discovery and translation of several biomarkers as well as developing evidence-based models that should help clinicians stratify patients with cancer in order to provide each individual with the appropriate care. His organization’s work is set on the shoulders of the Human Genome Project, and could present us with a vision – and hope – for the future of cancer treatment.

This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at